ReviewCureus2025
Role of Damage Control Surgery in Severe Liver Trauma: A Systematic Review of Mortality, Morbidity, and ICU Stay.
Review in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This systematic review evaluates the role of damage control surgery (DCS) in managing severe hepatic trauma (AAST grade III-V), focusing on mortality, morbidity, and ICU stay. A comprehensive search of PubMed, Embase, Scopus, and the Cochrane Library identified six studies with a combined sample size of 1,497 patients, analyzed according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 guidelines. DCS comprising perihepatic packing, temporary abdominal closure, and staged re-laparotomy was shown to improve short-term survival by rapidly controlling hemorrhage and stabilizing physiology in critically unstable patients. Evidence indicated that early re-laparotomy (within 24-48 hours) reduced ICU stay and postoperative complications compared with delayed re-exploration. Despite improved outcomes, mortality remained influenced by initial physiological instability and associated injuries. Most studies presented a moderate risk of bias due to retrospective designs and heterogeneity in protocols. Overall, DCS remains a cornerstone in the management of severe liver trauma, and future multicenter prospective studies are needed to refine operative timing, standardize protocols, and optimize patient outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.